Literature DB >> 17445108

Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.

Stephen D Silberstein1, David Dodick, Fred Freitag, Starr H Pearlman, Steven R Hahn, Ann I Scher, Richard B Lipton.   

Abstract

Comorbidity is defined as an illness that occurs more frequently in association with a specific disorder than would be found as a coincidental association in the general population. Conditions that are frequently comorbid with migraine include depression, anxiety, stroke, epilepsy, sleep disorders, and other pain disorders. In addition, many common illnesses occur concomitantly (at the same time) with migraine and influence the treatment choice. Migraine management, and especially migraine prevention, can be challenging when patients have comorbid or concomitant illnesses. The objectives of this initiative are to review the literature on managing patients who have migraine and common comorbidities, present additional clinical approaches for care of these difficult patients, and evaluate the areas in which research is needed to establish evidence-based guidelines for the management of migraine with associated comorbid conditions.

Entities:  

Mesh:

Year:  2007        PMID: 17445108     DOI: 10.1111/j.1526-4610.2007.00760.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  16 in total

Review 1.  Controversies in migraine: monotherapy.

Authors:  Domenico D'Amico
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine.

Authors:  Leda Marina Pomes; Giovanna Gentile; Maurizio Simmaco; Marina Borro; Paolo Martelletti
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

Review 3.  Emerging Treatment Targets for Migraine and Other Headaches.

Authors:  Zachariah Bertels; Amynah Amir Ali Pradhan
Journal:  Headache       Date:  2019-07       Impact factor: 5.887

Review 4.  Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents.

Authors:  William Qubty; Amy A Gelfand
Journal:  Curr Pain Headache Rep       Date:  2016-12

Review 5.  Cerebral angiopathies as a cause of ischemic stroke in children: differential diagnosis and treatment options.

Authors:  Hans-Jakob Steiger; Daniel Hänggi; Birgit Assmann; Bernd Turowski
Journal:  Dtsch Arztebl Int       Date:  2010-12-03       Impact factor: 5.594

6.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

7.  Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study.

Authors:  Deborah A Stokes; Martha S Lappin
Journal:  Behav Brain Funct       Date:  2010-02-02       Impact factor: 3.759

Review 8.  When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?

Authors:  Domenico D'Amico; Massimo Leone; Licia Grazzi; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 9.  Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications.

Authors:  S M Baskin; Todd A Smitherman
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 10.  Psychiatric comorbidities of episodic and chronic migraine.

Authors:  Dawn C Buse; Stephen D Silberstein; Aubrey N Manack; Spyros Papapetropoulos; Richard B Lipton
Journal:  J Neurol       Date:  2012-11-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.